Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BMP1 | P13497 | 3/20 | 0.51 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.40 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 4/20 | 0.33 |
| ▸ | MMP9 | P14780 | 4/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | ANPEP | P15144 | 1/20 | 0.31 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21172264 | 1.00 | BMP1 (0.51) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL14490962 | 0.83 | KMT2A (0.41) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL16594959 | 0.83 | KMT2A (0.41) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL18122802 | 0.83 | KMT2A (0.41) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL11933753 | 0.82 | BMP1 (0.55) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL23468491 | 0.81 | BMP1 (0.56) | BMP1ANPEPENPEPFOLH1MMP8 | |
| SCHEMBL13233708 | 0.81 | KMT2A (0.40) | BMP1DPP4DPP8DPP9KMT2A | |
| SCHEMBL22300362 | 0.81 | BMP1 (0.42) | BMP1MMP2MMP9L3MBTL1ANPEP | |
| SCHEMBL13218843 | 0.81 | BMP1 (0.56) | BMP1ANPEPENPEPFOLH1MMP8 | |
| SCHEMBL8139 | 0.81 | KMT2A (0.50) | BMP1DPP4DPP8DPP9KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827906-B2 | Adeno-associated virus (AAV) clade f vector and uses therefor | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230287451-A1 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-09-14 | — | — | US | disclosed |
| US-20230265459-A1 | Compositions Useful in Treatment of Spinal Muscular Atrophy | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-08-24 | — | — | US | disclosed |
| US-20230190966-A1 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-06-22 | — | — | US | disclosed |
| US-20230190966-A1 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-06-22 | — | — | US | disclosed |
| US-11578341-B2 | Compositions useful in treatment of spinal muscular atrophy | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-02-14 | — | — | US | disclosed |
| US-20230040603-A1 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-02-09 | — | — | US | disclosed |
| US-20230002788-A1 | AAV3B VARIANTS WITH IMPROVED PRODUCTION YIELD AND LIVER TROPISM | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-01-05 | — | — | US | disclosed |
| US-20220220453-A1 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2022-07-14 | — | — | US | disclosed |
| US-20220204990-A1 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2022-06-30 | — | — | US | disclosed |
| US-20200390888-A1 | NOVEL AAV MEDIATED INFLUENZA VACCINES | JANSSEN BIOTECH, INC. | 2020-12-17 | — | — | US | disclosed |
| US-20200056205-A1 | Compositions Useful in Treatment of Spinal Muscular Atrophy | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2020-02-20 | — | — | US | disclosed |
| US-20200056159-A1 | NOVEL ADENO-ASSOCIATED VIRUS (AAV) CLADE F VECTOR AND USES THEREFOR | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2020-02-20 | — | — | US | disclosed |
| US-8119411-B2 | Method for analyzing C-terminal amino acid sequence of peptide using mass spectrometry | NEC CORPORATION (JP) | 2012-02-21 | — | — | US | disclosed |
| WO-2012010516-A1 | GROWTH HORMONE CONJUGATES | NOVO NORDISK HEALTH CARE AG (CH) | 2012-01-26 | — | — | WO | disclosed |
| US-20110183428-A1 | METHOD FOR ANALYZING C-TERMINAL AMINO ACID SEQUENCE OF PEPTIDE USING MASS SPECTROMETRY | NEC CORPORATION (JP) | 2011-07-28 | — | — | US | disclosed |
| US-7879616-B2 | Method for analyzing C-terminal amino acid sequence of peptide using mass spectrometry | NEC CORPORATION (JP) | 2011-02-01 | — | — | US | disclosed |
| US-7879616-B2 | Method for analyzing C-terminal amino acid sequence of peptide using mass spectrometry | NEC CORPORATION (JP) | 2011-02-01 | — | — | US | disclosed |
| US-20100222547-A1 | Integrated Photoactive Peptides and Uses Thereof | MALLINCKRODT INC. | 2010-09-02 | — | — | US | disclosed |
| US-20100197185-A1 | LOW AND ULTRA-LOW FORMALDEHYDE EMISSION BINDERS FOR NON-WOVEN GLASS MAT | SAINT-GOBAIN TECHNICAL FABRICS AMERICA, INC. | 2010-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230040603-A1 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | GALC, GBA1, GLA | BMP1 1581/4885DPP4 2218/4885DPP8 554/4885 |
| US-20200056159-A1 | NOVEL ADENO-ASSOCIATED VIRUS (AAV) CLADE F VECTOR AND USES THEREFOR | VSIG8, ASNS, FARSB | BMP1 1151/4885DPP4 1710/4885DPP8 112/4885 |
| US-20220204990-A1 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | ELAVL1, ELAVL3, ANKRD54 | BMP1 3630/4885DPP4 3704/4885DPP8 2109/4885 |
| US-20230265459-A1 | Compositions Useful in Treatment of Spinal Muscular Atrophy | SMN1; SMN2, SRP68, HNRNPH1 | BMP1 2656/4885DPP4 4785/4885DPP8 3195/4885 |
| US-20230190966-A1 | COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS | GALC, GBA1, GBA2 | BMP1 2860/4885DPP4 2953/4885DPP8 1889/4885 |
| US-20200056205-A1 | Compositions Useful in Treatment of Spinal Muscular Atrophy | SMN1; SMN2, SRP68, HNRNPH1 | BMP1 2656/4885DPP4 4785/4885DPP8 3195/4885 |
| US-20100222547-A1 | Integrated Photoactive Peptides and Uses Thereof | DNPEP, PTMS, VIP | BMP1 131/4885DPP4 38/4885DPP8 76/4885 |
| US-11827906-B2 | Adeno-associated virus (AAV) clade f vector and uses therefor | ASNS, VSIG8, FARSB | BMP1 933/4885DPP4 1734/4885DPP8 118/4885 |
| US-20100197185-A1 | LOW AND ULTRA-LOW FORMALDEHYDE EMISSION BINDERS FOR NON-WOVEN GLASS MAT | FUS, WASF2, UFM1 | BMP1 1819/4885DPP4 3867/4885DPP8 4108/4885 |
| US-20200390888-A1 | NOVEL AAV MEDIATED INFLUENZA VACCINES | VSIR, VSIG8, IGLV6-57 | BMP1 4036/4885DPP4 3730/4885DPP8 2667/4885 |
| US-11578341-B2 | Compositions useful in treatment of spinal muscular atrophy | SMN1; SMN2, SRP68, HNRNPH1 | BMP1 2656/4885DPP4 4785/4885DPP8 3195/4885 |
| US-20230287451-A1 | NOVEL AAV CAPSIDS AND COMPOSITIONS CONTAINING SAME | ELAVL1, VSIG8, ELAVL3 | BMP1 3634/4885DPP4 4057/4885DPP8 2289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.